AU2003280821A8 - Beauveriolide derivative - Google Patents

Beauveriolide derivative

Info

Publication number
AU2003280821A8
AU2003280821A8 AU2003280821A AU2003280821A AU2003280821A8 AU 2003280821 A8 AU2003280821 A8 AU 2003280821A8 AU 2003280821 A AU2003280821 A AU 2003280821A AU 2003280821 A AU2003280821 A AU 2003280821A AU 2003280821 A8 AU2003280821 A8 AU 2003280821A8
Authority
AU
Australia
Prior art keywords
beauveriolide
derivative
beauveriolide derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2003280821A
Other versions
AU2003280821A1 (en
Inventor
Satoshi Omura
Hiroshi Tomoda
Toshiaki Sunazuka
Kenichiro Nagai
Takashi Takahashi
Takayuki Doi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemgenesis Inc
Original Assignee
Chemgenesis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemgenesis Inc filed Critical Chemgenesis Inc
Publication of AU2003280821A1 publication Critical patent/AU2003280821A1/en
Publication of AU2003280821A8 publication Critical patent/AU2003280821A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0827Tripeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
AU2003280821A 2003-11-17 2003-11-17 Beauveriolide derivative Abandoned AU2003280821A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2003/014577 WO2005047312A1 (en) 2003-11-17 2003-11-17 Beauveriolide derivative

Publications (2)

Publication Number Publication Date
AU2003280821A1 AU2003280821A1 (en) 2004-06-06
AU2003280821A8 true AU2003280821A8 (en) 2005-06-06

Family

ID=34587065

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003280821A Abandoned AU2003280821A1 (en) 2003-11-17 2003-11-17 Beauveriolide derivative

Country Status (2)

Country Link
AU (1) AU2003280821A1 (en)
WO (1) WO2005047312A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010126454A (en) * 2008-11-25 2010-06-10 Kitasato Institute Beauveriolide having acat2 inhibitory activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002275194A (en) * 2001-03-21 2002-09-25 Kitasato Gakuen New fo-6979-m0 substance, fo-6979-m1 substance, fo-6979-m2 substance, fo-6979-m3 substance and fo-6979-m4 substance and method for producing the same

Also Published As

Publication number Publication date
WO2005047312A1 (en) 2005-05-26
AU2003280821A1 (en) 2004-06-06

Similar Documents

Publication Publication Date Title
HK1091204A1 (en) Heteroarylcarbamoylbenzene derivative
IL176562A0 (en) Amidopyrazole derivative
HK1088602A1 (en) 2-pyridinecarboxamide derivatives
HK1088326A1 (en) Piperidine-benzenesulfonamide derivatives
HK1089443A1 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
GB0317665D0 (en) Qinazoline derivatives
ZA200603879B (en) Substituted indazole-O-glucosides
IL175490A0 (en) Substituted indazole-o-glucosides
ZA200603880B (en) Substituted indole-O-glucosides
PL1682493T3 (en) Amidoacetonitrile derivatives
EP1680131A4 (en) Substituted indole-o-glucosides
IL175189A0 (en) N-thiazol-2-yl-benzamide derivatives
DE502004003476D1 (en) Standfuss
ZA200600430B (en) Substituted spirobenzazepines
DE502004004146D1 (en) Pyrazolverbindungen
SI1706373T1 (en) Amidoacetonitrile derivatives
DE112004002769D2 (en) Schienengeführtes transportsystem
DE10394343D2 (en) Berührungslose biometrische erkennung
GB0312368D0 (en) Novel ureido- and amido-pyrazolone derivatives
GB0319793D0 (en) Pyridinylmorpholine derivatives
AU2003280821A8 (en) Beauveriolide derivative
TWI341309B (en) Heteroarylcarbamoylbenzene derivatives
AU2833P (en) Baltinrose Gaura lindheimeri
AU2834P (en) Baltinblus Gaura lindheimeri
AU2003280822A8 (en) Beauveriolide derivatives

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 19, NO 28, PAGE(S) 1849 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME CHEMGENESIS INCORPORATED, APPLICATION NO. 2003280821, UNDER INID (43) CORRECT THE DATE TO READ 06.06.2005

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase